Cargando…

Editorial: Mitochondria, metabolism and cardiovascular diseases

Detalles Bibliográficos
Autores principales:	Koga, Jun-ichiro, Sun, Xinghui, Ushio-Fukai, Masuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437701/ https://www.ncbi.nlm.nih.gov/pubmed/36061554 http://dx.doi.org/10.3389/fcvm.2022.996739

Ejemplares similares

Cross-Talk between NADPH Oxidase and Mitochondria: Role in ROS Signaling and Angiogenesis
por: Fukai, Tohru, et al.
Publicado: (2020)

Editorial: Metabolic regulation in cardiovascular homeostasis and disease
por: Song, Kunhua, et al.
Publicado: (2022)

Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017)

Editorial: Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease
por: Yan, Tong, et al.
Publicado: (2022)

Embracing Diversity, Equity, and Inclusion in the Scientific Community—Viewpoints of the Diversity, Equity, and Inclusion Committee of the North American Vascular Biology Organization
por: Garelnabi, Mahdi, et al.
Publicado: (2022)

Editorial: Metabolism Linking Immunity and Inflammatory Phenotypes in Cardiovascular Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases
por: Liu, Yuliang, et al.
Publicado: (2023)

Editorial: Decoding complexity: new insights into the cellular and molecular mechanisms of cardiovascular and metabolic diseases
por: Liu, Chia-Feng, et al.
Publicado: (2023)

Editorial: The regulatory role of metabolic organ-secreted factors in the development of cardiovascular diseases
por: You, Mei, et al.
Publicado: (2023)

Editorial: Hypoxia in cardiovascular disease
por: Bilo, Grzegorz, et al.
Publicado: (2022)

Editorial: Autoimmunity and cardiovascular diseases
por: Khandker, Shahad Saif, et al.
Publicado: (2023)

Editorial: Cardiovascular imaging in the integrated assessment of metabolic health
por: Thomaides-Brears, Helena B., et al.
Publicado: (2023)

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
por: Velmurugan, Ganesan, et al.
Publicado: (2022)

Editorial: Epigenetic Regulation in Cardiovascular Diseases
por: Pillai, Indulekha C. L., et al.
Publicado: (2022)

Editorial: Immunomodulatory Approaches in Cardiovascular Diseases
por: Booz, George W., et al.
Publicado: (2022)

Editorial: Cardiovascular involvement in autoimmune diseases
por: Mavrogeni, Sophie I., et al.
Publicado: (2022)

Editorial: Bio-materials for Cardiovascular Diseases
por: Campagnolo, Paola, et al.
Publicado: (2021)

Editorial: Mitochondrial Dysfunction and Cardiovascular Diseases
por: Sadoshima, Junichi, et al.
Publicado: (2021)

Editorial: Nutrition and Metabolism in Rheumatic Diseases
por: Canhao, Helena, et al.
Publicado: (2019)

Editorial: Recent advances in mitochondria-associated endoplasmic reticulum membranes (MAMs) in heart-related diseases
por: Yang, Yang, et al.
Publicado: (2023)

Editorial: Highlights in Lipids in Cardiovascular Disease: 2021
por: Boucheniata, Chaymae, et al.
Publicado: (2022)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Editorial: Mitophagy and mitochondrial proteostasis in cardiovascular diseases
por: Dymkowska, Dorota, et al.
Publicado: (2022)

Editorial: Insights in lipids in cardiovascular disease: 2021
por: Levitan, Irena, et al.
Publicado: (2022)

Editorial: Cardiovascular responses and diseases at high altitude
por: Huang, Lan
Publicado: (2022)

Editorial: Vascular Endothelial Glycocalyx in Cardiovascular Disease
por: Tomita, Hiroyuki, et al.
Publicado: (2022)

Editorial: Sleep disorders, hypertension and cardiovascular diseases
por: Bisogni, Valeria, et al.
Publicado: (2022)

Editorial: The Non-coding Genome and Cardiovascular Disease
por: Mishra, Paras Kumar, et al.
Publicado: (2019)

Editorial: Cardioimmunology: Inflammation and Immunity in Cardiovascular Disease
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Editorial: Health technology assessment in cardiovascular diseases
por: Shah, Komal, et al.
Publicado: (2023)

Editorial: Cardiovascular cell senescence in aging and disease
por: Gaetano, Carlo, et al.
Publicado: (2023)

Editorial: Micro- and macronutrient malnutrition in cardiovascular disease
por: Hobkirk, J. P., et al.
Publicado: (2023)

Editorial: Endothelial-to-mesenchymal transition in cardiovascular disease
por: Alfaidi, Mabruka, et al.
Publicado: (2023)

Editorial: Thrombo-inflammation in cardiovascular disease and health
por: Jung, Richard G., et al.
Publicado: (2023)

Editorial: Immune and autoimmune mechanisms in cardiovascular disease
por: Winkels, Holger, et al.
Publicado: (2023)

Editorial: Mitochondrial quality control in cardiovascular diseases
por: Zhang, Miao, et al.
Publicado: (2023)

The role of mitochondria-associated membranes mediated ROS on NLRP3 inflammasome in cardiovascular diseases
por: Zhao, Jiahao, et al.
Publicado: (2022)

Editorial: Cardiovascular engineering
por: Ozturk, Caglar, et al.
Publicado: (2022)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Editorial: Physical activity and exercise for the prevention and management of cardiovascular risk and cardiovascular disease
por: Volterrani, Maurizio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ftdag2a1lsbjs9tiqh3spi6vcj